Table 1 Baseline characteristics
Demographic variables | Patients (n = 115) |
|---|---|
Age (y), median (IQR) | 67.0 (57.0–74.0) |
Female, n (%) | 33 (28.6) |
Baseline NIHSS, median (IQR) | 12.0 (8.0–16.0) |
Baseline ASPECTS, median (IQR) | 8.0 (7.0–9.0) |
Medical history | |
Hypertension, n (%) | 80 (69.5) |
Diabetes, n (%) | 31 (26.9) |
Hyperlipidemia, n (%) | 27 (23.4%) |
Atrial fibrillation, n (%) | 23 (20.0) |
Smoking, n (%) | 18 (15.6) |
Obesity, n (%) | 25 (21.7) |
Anticoagulant therapy before AIS, n (%) | 6 (5.2) |
Intravenous alteplase treatment, n (%) | 13 (11.3) |
Systolic blood pressure (mmHg), median (IQR) | 151.5 (140.0–164.0) |
Diastolic blood pressure (mmHg), median (IQR) | 88.0 (78.7–98.0) |
Vascular occlusion site, n (%) | |
ICA | 11 (9.6) |
MCA | 83 (72.1) |
ICA + MCA | 21 (18.3) |
Stroke etiology, n (%) | |
Atherosclerosis | 74 (64.3) |
Cardioembolic | 40 (34.8) |
Other | 1 (0.9) |
Onset to door (min), median (IQR) | 717.5 (437.2–973.0) |
Onset to recanalization (min), median (IQR) | 786.0 (492.0–1113.7) |
Number of passes, median (IQR) | 1.0 (1.0–2.0) |
Laboratory testing | |
Platelet count, median (IQR) | 210.0 (164.0–242.0) |
INR, median (IQR) | 0.9 (0.9–1.1) |
APTT, median (IQR) | 33.5 (31.3–36.5) |
D-dimer, median (IQR) | 0.5 (0.3–1.4) |
ALT, median (IQR) | 17.0 (13.0–25.0) |
AST, median (IQR) | 20.0 (17.0–24.7) |
HbA1C (%), median (IQR) | 6.1 (5.7–6.8) |
Infarct core volume (ml), median (IQR) | 4.3 (0.6–14.3) |
Hypoperfusion volume, median (IQR) | 112.8 (75.9–164.4) |
sICH | 16 (13.9) |
ICH | |
No | 60 (52.2) |
HI-1 | 16 (13.9) |
HI-2 | 17 (14.8) |
PH-1 | 15 (13.0) |
PH-2 | 7 (6.1) |